最新新聞
|
|
|
Dec. 24. 2020- VSTRIP COVID-19 ANTIGEN RAPID TEST ACQUIRED PROVISIONAL AUTHORIZATION FROM SINGAPORE HEALTH SCIENCES AUTHORITY (HSA) Vstrip COVID-19 Antigen Rapid Test acquired provisional authorization from Singapore Health Sciences Authority (HSA). |
 |
|
Dec. 02. 2020- VSTRIP COVID-19 ANTIGEN RAPID TEST OBTAINS CE MARKING PANION & BF BIOTECH INC. XIZHI FACTORY is notified by Obelis s.a. on 2020/12/01 that Vstrip COVID-19 Antigen Rapid Test is in compliance with European Council Directive 98/97/EC – article 10 requirements. |
 |
|
Sep .25. 2020- VSTRIP COVID-19 ANTIGEN RAPID TEST IS VALIDATED AND FOUND TO BE SATISFACTORY BY INDIA COUNCIL OF MEDICAL RESEARCH (ICMR). Vstrip COVID-19 Antigen Rapid Test is validated and found to be satisfactory by India Council of Medical Research (ICMR). |
 |
|
Aug .27. 2020- VSTRIP COVID-19 ANTIGEN RAPID TEST ACQUIRED APPROVAL FROM TAIWAN MINISTRY OF HEALTH AND WELFARE Vstrip COVID-19 Antigen Rapid Test is approved by Taiwan Ministry of Health and Welfare in response to emergency public health circumstances. Approval Number: Case-Specific Approval of Disease Control for Manufacture No. 1096813815 |
> |
ZH_TW 
EN